5 results match your criteria: "Nuovo S Giovanni di Dio Hospital[Affiliation]"
Expert Rev Clin Immunol
November 2019
Rheumatology Department, Hospital of Prato, Prato, Italy.
: In recent years, biosimilars of reference adalimumab (re-ADA), etanercept (re-ETN) and infliximab (re-IFX) have been licensed. In the absence of specific controlled studies, by the extrapolation principle, biosimilars have been approved for the treatment of psoriatic arthritis (PsA).: To assess the efficacy and safety of biosimilars in PsA, the literature, present until 30 June 2019, was reviewed.
View Article and Find Full Text PDFAnn Rheum Dis
February 2020
Rheumatology Clinic, Azienda USL Toscana Centro, Nuovo S Giovanni di Dio Hospital, Florence, Italy.
Ann Rheum Dis
April 2019
Rheumatology Clinic, Azienda USL Toscana Centro, Nuovo S Giovanni di Dio Hospital, Florence, Italy.
Ann Rheum Dis
April 2019
Rheumatology Clinic, Azienda USL Toscana Centro, Nuovo S Giovanni di Dio Hospital, Florence, Italy.
Eur Heart J Cardiovasc Imaging
May 2017
Centro Medico Diagnostico, Naples, Italy.
Aims: The determinants of discrepancies among two-dimensional echocardiographic (2D-E) methods for left atrial volume (LAV) assessment are poorly investigated.
Methods And Results: Maximal LAV was measured in 613 individuals (282 healthy subjects,180 athletes, and 151 hypertensives; age 45 ± 20 years, 62% male) using the ellipsoid model (LAVEllips), the area-length method (LAVAL), and the Simpson's rule (LAVSimps). On the basis of a mathematical model, two left atrial (LA) geometry indexes were tested as predictors of discrepancies between methods: the ratio between LA medial-lateral diameter (MLD) and LA anteroposterior diameter (APD); and the ratio between LA area in the four-chamber view and that of an ellipse with the same diameters [deviation from ellipse (DE)-coefficient].